Categories LATEST

T-Mobile Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

T-Mobile US, Inc. (NASDAQ: TMUS), a leading telecommunications company in the US, will be reporting earnings for the second quarter of 2023 today at 4:00 pm ET.

Listen to T-Mobile’s Q2 2023 earnings call live and read the real-time transcript

It is widely estimated that T-Mobile generated earnings of $1.69 per share in the June quarter, compared to a loss of 9 cents in the second quarter of 2022. Wall Street expects the company’s revenues to come in at $19.31 billion, which would be down 2% from the revenue it generated in the prior-year quarter.

In the first quarter of 2023, T-Mobile’s net profit rose sharply to $1.94 billion or $1.58 per share from $713 million or 57 cents per share in the corresponding period last year. Earnings benefitted from a marked decrease in operating expenses. Revenues, meanwhile, declined to $19.63 billion from $20.12 billion last year despite a healthy improvement in service revenues. The service growth and increased synergy realization drove up core adjusted EBITDA to $7.1 billion.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note

UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal

Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities

Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on

AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%

AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close